R.P. Welltar Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -59.34%
- Profit Growth -222.69%
- Ebitda -256.74%
- Net Worth -1559.77%
- Total Assets -74.79%
About R.P. Welltar
R.P. Welltar Limited (RWL) is a Public Limited Indian Non-Government Company incorporated in India on 11 November 2010 and has a history of 14 years and two months. Its registered office is in Karnal, Haryana, India.
The Corporate was formerly known as R.P. Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Rani, Mangat Mittal, and Nidhi Singhal serve as directors at the Company.
Company Details
-
Location
Karnal, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100HR2010PLC041525
-
Company No.
041525
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
11 Nov 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at R.P. Welltar?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Rani
|
Additional Director | 11-Mar-2017 | Current |
|
Mangat Mittal
|
Additional Director | 11-Mar-2017 | Current |
|
Nidhi Singhal
|
Additional Director | 10-Aug-2017 | Current |
Financial Performance of R.P. Welltar.
R.P. Welltar Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 59.34% decrease. The company also saw a substantial fall in profitability, with a 222.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1559.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.P. Welltar?
In 2017, R.P. Welltar had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bharat Hospitals LimitedKamlesh Rani, Mangat Mittal and 1 more are mutual person
-
Namastey Jee Industries Limited
Kamlesh Rani is a mutual person
-
R.P. Gums & Chemcials Limited
Kamlesh Rani and Mangat Mittal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R.P. Welltar?
Unlock and access historical data on people associated with R.P. Welltar, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.P. Welltar, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.P. Welltar's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
